Last10K.com

Pieris Pharmaceuticals, Inc. (PIRS) SEC Filing 8-K Material Event for the period ending Thursday, August 4, 2022

Pieris Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1583648 Ticker: PIRS

View differences made from one to another to evaluate Pieris Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pieris Pharmaceuticals, Inc..

Continue

Assess how Pieris Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pieris Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover Page Cover Page
Ticker: PIRS
CIK: 1583648
Form Type: 8-K Corporate News
Accession Number: 0001583648-22-000061
Submitted to the SEC: Thu Aug 04 2022 8:47:31 AM EST
Accepted by the SEC: Thu Aug 04 2022
Period: Thursday, August 4, 2022
Industry: Commercial Physical And Biological Research
Events:
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/pirs/0001583648-22-000061.htm